Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus

NCT03552991 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2018-06-12

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a commercial dietary fiber supplement on patients with type 2 diabetes mellitus, in the way of glucose control, insulin action in the body, and the gut microbiota (bacteria) abundance.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Agiocur Pregranules

6g before breakfast and 12g after dinner for first 28 days, and no medication for next 28 days for washout

Sponsors & Collaborators

  • Bukwang Pharmaceutical, Co., Ltd.

    collaborator INDUSTRY
  • ChunLab, Inc.

    collaborator UNKNOWN
  • Samsung Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-10-31
Completion
2018-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03552991 on ClinicalTrials.gov